Osteosarcoma News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Finding a future for osteosarcoma patients - American Veterinary Medical Association



American Veterinary Medical Association
 
Finding a future for osteosarcoma patients 
American Veterinary Medical Association
The first dog, Hessa, had chondrosarcoma. She was not a candidate for surgery, and the tumor was quite aggressive. The second and third dogs, Roddy and Maxine, had osteosarcoma. Both had amputations. Roddy started chemotherapy but developed lung ...

 


Vaccine holds promise for treating osteosarcoma in dogs - American Veterinary Medical Association



American Veterinary Medical Association
 
Vaccine holds promise for treating osteosarcoma in dogs 
American Veterinary Medical Association
Veterinarians in the audience wanted to know when they could get their hands on the new treatment. Dr. Sue Ettinger, a veterinary oncologist, had mentioned a promising vaccine for osteosarcoma in dogs when she presented "Osteosarcoma Survival Guide" ...

 


LncRNA expression and implication in osteosarcoma: a systematic review and meta-analysis - Dove Medical Press



LncRNA expression and implication in osteosarcoma: a systematic review and meta-analysis 
Dove Medical Press
Purpose: Osteosarcoma is the most prevalent primary bone tumor in children, adolescents, and older adults, typically presenting with poor survival outcomes. In recent years, ample evidence has shown that many long noncoding RNAs (lncRNAs) have been ...

 


Cam Brown's battle against Osteosarcoma | News | wtxl.com - WTXL ABC 27



Cam Brown's battle against Osteosarcoma | News | wtxl.com 
WTXL ABC 27
Cam Brown battled an aggressive from of bone cancer, Osteosarcoma. This particular cancer is rare, but more than half who are diagnosed with it are younger ...

and more » 


Osteosarcoma Market is Expected to Grow at a CAGR of 8.7% by 2025 - Research of Market



Osteosarcoma Market is Expected to Grow at a CAGR of 8.7% by 2025 
Research of Market
Osteosarcoma-Mechanism of action Insights, 2017?, report provides comprehensive insights of the ongoing therapeutic research and development across Osteosarcoma. The report provides a complete understanding of the pipeline activities covering all ...

and more » 


Rh-Endostatin in perioperative period improves osteosarcoma outcomes - Healio



Rh-Endostatin in perioperative period improves osteosarcoma outcomes 
Healio
WAILEA, Hawaii ? Perioperative administration of Rh-Endostatin with traditional chemotherapy improved outcomes for patients with stage IIB osteosarcoma, according to study results presented at Connective Tissue Oncology Society. ?[The regimen] could ...

 


Low-grade central osteosarcoma in proximal humerus: a rare entity - Dove Medical Press



Low-grade central osteosarcoma in proximal humerus: a rare entity 
Dove Medical Press
Abstract: Low-grade central osteosarcoma is a rare subtype of tumor with low-grade malignancy. Currently, wide resection with negative resection margin is the standard treatment for this disease. The role of neoadjuvant chemotherapy in low-grade ...

 


CDX-011 Does Not Benefit Patients With Osteosarcoma - Cancer Therapy Advisor



Cancer Therapy Advisor
 
CDX-011 Does Not Benefit Patients With Osteosarcoma 
Cancer Therapy Advisor
CDX-011, which suppresses GPNMB protein levels, is not effective for slowing tumor progression in patients with previously treated osteosarcoma, according to an oral presentation at the Connective Tissue Oncology Society (CTOS) 2017 Annual Meeting.1.

 


Novel Agent Fails to Show Sufficient Activity in Recurrent Osteosarcoma - Cancer Network



Novel Agent Fails to Show Sufficient Activity in Recurrent Osteosarcoma 
Cancer Network
The GPNMB-targeted agent known as glembatumumab vedotin was reasonably well tolerated and showed some activity in a phase II study of recurrent/refractory osteosarcoma, but this activity was not enough to continue the drug's evaluation in this setting ...

 


Medicine scholars develop innovative targeted delivery system for ... - Medical Xpress



Medicine scholars develop innovative targeted delivery system for ... 
Medical Xpress
Chinese Medicine scholars at Hong Kong Baptist University (HKBU) have succeeded in developing a novel targeted delivery system for CRISPR/Cas9 to ...

and more »